Literature DB >> 22356784

Risk factors for in-hospital mortality in cirrhotic patients with oesophageal variceal bleeding.

Rute Maria Cerqueira1, Luis Andrade, Manuel Rodriguez Correia, Carolina Duesca Fernandes, Maria Conceição Manso.   

Abstract

INTRODUCTION: Oesophageal variceal bleeding (OVB) is a high mortality rate complication in patients with cirrhosis. The aim of this study was to assess the risk factors for in-hospital mortality (IHM) in cirrhotic patients with OVB. PATIENTS AND METHODS: The study cohort included 102 patients (average age, 55.4 ± 12.6 years, 71.6% men) consecutively admitted to our hospital with OVB. All the patients underwent upper endoscopy within 12 h and octeotride or terlipressin therapy was started at admission and continued for 5 days. To calculate Model for End-Stage Liver Disease (MELD) and Child-Turcotte-Pugh scores, laboratory test data from blood samples taken within 6 h of admission were used.
RESULTS: The IHM was 18.6% [19 patients; confidence interval (95% CI): 11.1-26.2%]. In the univariate analysis, transfusion with 2 or more units of packed red blood cells [PRBC; P=0.038; odds ratio (OR)=7.8; 95% CI: 1.2-61.3], platelets of 100/ml or less (P=0.014; OR=3.6; 95% CI: 1.2-10.3), Child-Turcotte-Pugh score of 10 or more (P=0.002; OR=4.0; 95% CI: 1.2-13.2) and MELD of 18 or more (P=0.044; OR=2.8; 95% CI: 1.1-8.1) were associated with IHM. In the multivariate analysis, transfusion with 2 or more units of PRBC (P=0.076; OR=6.7; 95% CI: 0.82-54.8), platelets of 100/ml or less (P=0.031; OR=3.4; 95% CI: 1.1-10.6) and MELD of 18 or more (P=0.048; OR=3.2; 95% CI: 1.02-10.1) remained independently associated with IHM. Applying a receiver operating characteristic analysis, the area under the curve derived from the multivariate analysis model was 0.76 (95% CI: 0.64-0.88) for IHM.
CONCLUSION: Cirrhotic patients with OVB and MELD of 18 or more, platelets of 100/ml or less and requiring transfusion of 2 or more units of PRBC were at an increased risk of IHM. Overall, the logistic regression model correctly predicts 82.2% of IHM patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22356784     DOI: 10.1097/MEG.0b013e3283510448

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  17 in total

1.  Child-Pugh versus MELD score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis.

Authors:  Ying Peng; Xingshun Qi; Junna Dai; Hongyu Li; Xiaozhong Guo
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 2.  Model for End-stage Liver Disease.

Authors:  Ashwani K Singal; Patrick S Kamath
Journal:  J Clin Exp Hepatol       Date:  2012-12-01

3.  β-2 Adrenergic receptor gene polymorphism and response to propranolol in cirrhosis.

Authors:  De-Run Kong; Jin-Guang Wang; Bin Sun; Ming-Quan Wang; Chen Chen; Fang-Fang Yu; Jian-Ming Xu
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

Review 4.  Management of varices in patients with cirrhosis.

Authors:  Julia O'Brien; Christos Triantos; Andrew K Burroughs
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-04-02       Impact factor: 46.802

5.  Value of the APASL severity score in patients with acute variceal bleeding: a single center experience.

Authors:  Go Heun Kim; Jeong Han Kim; Yong Jin Kim; Soon Young Ko; Won Hyeok Choe; So Young Kwon; Chang Hong Lee
Journal:  Hepatol Int       Date:  2013-08-29       Impact factor: 6.047

6.  Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in Austria.

Authors:  Nikolaus Pfisterer; Caroline Schmidbauer; Florian Riedl; Andreas Maieron; Vanessa Stadlbauer; Barbara Hennlich; Remy Schwarzer; Andreas Puespoek; Theresa Bucsics; Maria Effenberger; Simona Bota; Michael Gschwantler; Markus Peck-Radosavljevic; Mattias Mandorfer; Christian Madl; Michael Trauner; Thomas Reiberger
Journal:  Wien Klin Wochenschr       Date:  2020-12-03       Impact factor: 1.704

7.  Variceal bleeding in cirrhotic patients: risk factors, evolution, treatment.

Authors:  Anca Romcea; Marcel Tanţău; Andrada Seicean; Oliviu Pascu
Journal:  Clujul Med       Date:  2013-05-09

8.  The etiology of upper gastrointestinal bleeding in cirrhotic patients.

Authors:  Anca Alexandra Romcea; Marcel Tanţău; Andrada Seicean; Oliviu Pascu
Journal:  Clujul Med       Date:  2013-02-04

Review 9.  Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine.

Authors:  Tsang Lau; Jawad Ahmad
Journal:  Hepat Med       Date:  2013-02-11

10.  Is MELD the best prognostic score in acute variceal bleeding? The jury is still out.

Authors:  Sreedhari Thayalasekaran; Emmanuel A Tsochatzis
Journal:  Ann Gastroenterol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.